Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00409682. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
ClinicalTrials.gov study NCT01831427. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
ClinicalTrials.gov study NCT03980483. IPD Sharing: YES. Countries: 10. Publications: 1.
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
ClinicalTrials.gov study NCT03556202. IPD Sharing: YES. Countries: 19. Publications: 1.
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
ClinicalTrials.gov study NCT00358436. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Oral DS107 in Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02211417. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Rimegepant in Moderate Plaque-type Psoriasis
ClinicalTrials.gov study NCT04629950. IPD Sharing: NO. Countries: 1. Publications: 15.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT03823391. IPD Sharing: YES. Countries: 7. Publications: 1.
Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
ClinicalTrials.gov study NCT03363854. IPD Sharing: NO. Countries: 8. Publications: 5.
Comparing Message-based Psychotherapy to Once-weekly, Video-based Psychotherapy for Moderate Depression and Anxiety
ClinicalTrials.gov study NCT05467787. IPD Sharing: YES. Countries: 1. Publications: 1.
Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension
ClinicalTrials.gov study NCT01601470. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT04886063. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03443024. IPD Sharing: YES. Countries: 1. Publications: 2.
Eltrombopag for Moderate Aplastic Anemia
ClinicalTrials.gov study NCT01328587. IPD Sharing: Not stated. Countries: 1. Publications: 5.
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
ClinicalTrials.gov study NCT03748706. IPD Sharing: NO. Countries: 1. Publications: 3.
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
ClinicalTrials.gov study NCT00893789. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
ClinicalTrials.gov study NCT01709513. IPD Sharing: Not stated. Countries: 8. Publications: 7.
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT00620022. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
ClinicalTrials.gov study NCT05651711. IPD Sharing: YES. Countries: 21. Publications: 2.
A Moderate to Severe Rheumatoid Arthritis Study
ClinicalTrials.gov study NCT01721044. IPD Sharing: YES. Countries: 22. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.